Envista Holdings Corp
NVST20.500USD
-0.330-1.58%
Horário de mercado （ET）Cotações atrasadas em 15 min
3.42BValor de mercado
PerdaP/L TTM
Mais detalhes de Envista Holdings Corp Empresa
Envista Holdings Corporation is a dental products company. The Company provides dental consumables, solutions, technology, and services. It has approximately 30 dental brands, including Nobel Biocare, Ormco and Kerr united. The Company operates through two segments: Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems, and endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents and cements, and infection prevention products.
Informações da empresa
Código da empresaNVST
Nome da EmpresaEnvista Holdings Corp
Data de listagemSep 18, 2019
CEOMr. Paul A. Keel
Número de funcionários12300
Tipo de títulosOrdinary Share
Fim do ano fiscalSep 18
Endereço200 S. Kraemer Blvd., Bldg. E
CidadeBREA
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal92821
Telefone17148175418
Sitehttps://envistaco.com/en
Código da empresaNVST
Data de listagemSep 18, 2019
CEOMr. Paul A. Keel
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Paul A. Keel
Mr. Paul A. Keel
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
87.42K
-12.76%
Ms. Barbara B. Hulit
Ms. Barbara B. Hulit
Independent Director
Independent Director
79.82K
+15.06%
Ms. Veronica Acurio
Ms. Veronica Acurio
President - Orthodontics
President - Orthodontics
55.74K
+22.64%
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
55.74K
+22.64%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
50.61K
+26.02%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
50.60K
+26.03%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Independent Director
Independent Director
44.68K
+30.53%
Mr. Vivek Jain
Mr. Vivek Jain
Independent Director
Independent Director
43.62K
+31.51%
Mr. Mark E. Nance
Mr. Mark E. Nance
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
41.98K
-4.05%
Mr. J. Andrew Pierce
Mr. J. Andrew Pierce
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Paul A. Keel
Mr. Paul A. Keel
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
87.42K
-12.76%
Ms. Barbara B. Hulit
Ms. Barbara B. Hulit
Independent Director
Independent Director
79.82K
+15.06%
Ms. Veronica Acurio
Ms. Veronica Acurio
President - Orthodontics
President - Orthodontics
55.74K
+22.64%
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
55.74K
+22.64%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
50.61K
+26.02%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
50.60K
+26.03%
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
Northern America
324.40M
52.59%
Western Europe
143.30M
23.23%
Emerging markets
118.80M
19.26%
Other developed markets
30.40M
4.93%
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: sáb, 17 de mai
Atualizado em: sáb, 17 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
10.24%
BlackRock Institutional Trust Company, N.A.
9.28%
Ariel Investments, LLC
7.31%
Atlanta Capital Management Company, L.L.C.
7.31%
Dimensional Fund Advisors, L.P.
5.52%
Other
60.34%
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
10.24%
BlackRock Institutional Trust Company, N.A.
9.28%
Ariel Investments, LLC
7.31%
Atlanta Capital Management Company, L.L.C.
7.31%
Dimensional Fund Advisors, L.P.
5.52%
Other
60.34%
Tipos de investidores
Investidores
Proporção
Investment Advisor
58.23%
Investment Advisor/Hedge Fund
45.40%
Hedge Fund
8.82%
Research Firm
1.42%
Pension Fund
1.41%
Sovereign Wealth Fund
1.21%
Bank and Trust
0.61%
Individual Investor
0.55%
Family Office
0.05%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
734
200.23M
118.14%
-35.42M
2025Q1
767
200.87M
118.49%
-32.33M
2024Q4
774
200.73M
116.58%
-32.33M
2024Q3
769
198.37M
115.33%
-28.47M
2024Q2
775
193.95M
112.83%
-33.23M
2024Q1
793
187.23M
108.93%
-31.14M
2023Q4
800
189.02M
110.25%
-16.86M
2023Q3
779
181.32M
105.90%
-24.06M
2023Q2
772
187.89M
114.71%
-18.52M
2023Q1
783
191.23M
116.82%
-14.97M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
17.02M
10.04%
-218.34K
-1.27%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
15.43M
9.1%
+235.82K
+1.55%
Mar 31, 2025
Ariel Investments, LLC
12.14M
7.17%
+85.12K
+0.71%
Mar 31, 2025
Atlanta Capital Management Company, L.L.C.
12.14M
7.16%
+242.93K
+2.04%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
8.39M
4.95%
+1.63M
+24.03%
Mar 31, 2025
Harris Associates L.P.
8.68M
5.12%
-740.06K
-7.86%
Mar 31, 2025
Franklin Mutual Advisers, LLC
7.67M
4.52%
+817.48K
+11.93%
Mar 31, 2025
American Century Investment Management, Inc.
6.35M
3.75%
-552.57K
-8.00%
Mar 31, 2025
State Street Global Advisors (US)
5.68M
3.35%
+33.13K
+0.59%
Mar 31, 2025
Victory Capital Management Inc.
5.44M
3.21%
+3.35M
+161.26%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
SPDR S&P Health Care Equipment ETF
1.85%
Schwab Ariel Opportunities ETF
1.24%
Royce Quant Small-Cap Quality Value ETF
0.56%
JPMorgan Fundamental Data Science Mid Core ETF
0.55%
Pacer US Small Cap Cash Cows ETF
0.38%
iShares U.S. Medical Devices ETF
0.38%
Gotham 1000 Value ETF
0.36%
VictoryShares US Small Mid Cap Value Momentum ETF
0.32%
Global X US Cash Flow Kings 100 ETF
0.32%
DFA Dimensional US Small Cap Value ETF
0.26%
Ver Mais
SPDR S&P Health Care Equipment ETF
Proporção1.85%
Schwab Ariel Opportunities ETF
Proporção1.24%
Royce Quant Small-Cap Quality Value ETF
Proporção0.56%
JPMorgan Fundamental Data Science Mid Core ETF
Proporção0.55%
Pacer US Small Cap Cash Cows ETF
Proporção0.38%
iShares U.S. Medical Devices ETF
Proporção0.38%
Gotham 1000 Value ETF
Proporção0.36%
VictoryShares US Small Mid Cap Value Momentum ETF
Proporção0.32%
Global X US Cash Flow Kings 100 ETF
Proporção0.32%
DFA Dimensional US Small Cap Value ETF
Proporção0.26%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
